Diagnosis and Treatment of Intravascular Lymphomatosis

Authors:
  • NHNina Hurwitz
    Nina Hurwitz
  • EKEva Karamitopolou-Diamantis
    Eva Karamitopolou-Diamantis
  • APAlfonse Probst
    Alfonse Probst
  • RHRichard Herrmann
    Richard Herrmann
  • ASAndreas J. Steck
    Andreas J. Steck

Abstract
Objective To describe a patient with unusually good outcome of a rare, high-grade lymphoma that often involves the nervous system. Design Case report. Setting University hospital. Case A 70-year-old pharmacist first presented with meningoencephalitislike symptoms and 6 months later with acute confusional state followed by complex partial status epilepticus. Diagnosis of intravascular lymphomatosis was made using detection and biopsy of a bilateral adrenal tumor. Main Outcome and Results Polychemotherapy consisting of CHOP (cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone) led to complete remission. The patient's survival time currently exceeds 2½ years. Conclusions The possibility of intravascular lymphomatosis should be considered in adult patients with unclear meningoencephalitic syndrome, acute confusional state, dementia, or other unexplained neurologic conditions with signs of a systemic disease. In intravascular lymphomatosis, as in other high-grade non-Hodgkin lymphomas, CHOP polychemotherapy should be the standard treatment.